Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

FuturHealth Review

GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.

Last reviewed August 2026
3 studies cited
Fact-checked 12 August 2026Last updated 15 June 2026From $198 – $499/moEditor Score 4.0 / 5Trustpilot 4.6 · Excellent

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.

Who it's for: FuturHealth is for buyers who want behavioural support layered on top of pharmacology, a coach plus a GLP-1, not a GLP-1 alone. Worth the premium if you'll actually use the coaching.

Bottom line: Coaching is the differentiator. If you're going to use it, FuturHealth pulls ahead of cheaper, drug-only competitors. If you won't, save the money.

Pros
  • Coaching layer included in the subscription
  • Wide brand-name GLP-1 access
  • Oral GLP-1 pill option
Cons
  • Premium entry price
  • Coaching only matters if you actually use it

Pros & Cons In Detail

Coaching layer included in the subscription
In practice this is one of the differentiators that pushes FuturHealth's editor score above the category median.
Wide brand-name GLP-1 access
Carrying both compounded and FDA-approved options gives FuturHealth more flexibility if a patient needs to switch tracks for insurance, supply, or efficacy reasons mid-program.
Oral GLP-1 pill option
In practice this is one of the differentiators that pushes FuturHealth's editor score above the category median.
Premium entry price
Cost is in line with category leaders, not below them. readers shopping primarily on monthly out-of-pocket should weigh the alternatives in the listicle.
Coaching only matters if you actually use it
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

FuturHealth Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at FuturHealth.

Program / Membership FeeIncluded in monthly plan
Medication Cost (From)From $198 – $499/mo
What This Means For You

FuturHealth starts at $198/mo, which bundles GLP-1 medication (compounded semaglutide), provider oversight, and personalised nutrition and fitness coaching into one flat monthly subscription. Brand-name GLP-1 (Wegovy, Zepbound, Ozempic, Mounjaro) is available at clinic-published rates plus a service fee on top of the base plan. The coaching layer, dedicated nutrition and fitness support, is the key differentiator over cheaper drug-only competitors.

Who FuturHealth Is For

FuturHealth is for buyers who want behavioural support layered on top of pharmacology, a coach plus a GLP-1, not a GLP-1 alone. Worth the premium if you'll actually use the coaching.

How FuturHealth Markets Itself

Adults who want their GLP-1 prescription combined with structured nutrition and fitness coaching.

Signature Programs

  • ›Brand-name and compounded GLP-1
  • ›Oral GLP-1 pills
  • ›Personalised nutrition and fitness coaching

Medication Formulary

FDA-Approved Access
WegovyZepboundOzempicMounjaro
Full Formulary
compounded semaglutideoral glp-1 pills

The Bottom Line

Coaching is the differentiator. If you're going to use it, FuturHealth pulls ahead of cheaper, drug-only competitors. If you won't, save the money.

With an editor score of 4.0 / 5 across cost, experience, and trust, FuturHealth is one of the specialty options in the glp-1 weight loss category we cover.

See how FuturHealth compares in our full glp-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
  3. Garvey et al., NEJM 2022 (STEP 5) · Two-year STEP 5 data confirmed sustained 15.2% weight loss with semaglutide 2.4 mg.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

§ Readers Also Compared

How FuturHealth Stacks Up

Alternatives To FuturHealth

§ Continue Reading